— Know what they know.
Not Investment Advice

FHTX NASDAQ

Foghorn Therapeutics Inc.
1W: +3.0% 1M: -22.8% 3M: -27.4% YTD: -19.9% 1Y: +0.5% 3Y: -35.0% 5Y: -57.0%
$4.22
+0.06 (+1.44%)
 
Weekly Expected Move ±8.6%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $247.8M mcap · 27M float · 0.563% daily turnover · Short 58% of daily vol

📊 Key Metrics

TTM
$28M
Revenue
+20.1% YoY
$-75M
Net Income
+6.4% YoY
$-87M
Free Cash Flow
+8.8% YoY
92.7%
Gross Margin
-660.3%
Op. Margin
-608.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE97.8%
ROA-31.2%
ROIC28.2%

Valuation

P/E-3.9
P/B-3.8
EV/EBITDA-3.0

Leverage

Debt/Equity-0.38
Current Ratio2.73
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z-4.30
Beneish M-2.56

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms